Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Hormonal Contraception and Risk of Chlamydia and Gonorrhea
This study has been terminated.
Study NCT00091728 Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First Received: September 16, 2004 Last Updated: November 4, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chlamydia Infection
Neisseriaceae Infection
Additional conditions recognized in this trial
Chlamydia Infections
Communicable Diseases
Infection
Neisseriaceae Infections
More general conditions related to this trial
Bacterial Infections
Chlamydiaceae Infections
Genital Diseases, Female
Genital Diseases, Male
Gram-Negative Bacterial Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Bacterial
Interventions listed in this trial
Depo Medroxyprogesterone acetate
Combined oral contraceptives
Additional drug interventions recognized in this trial
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Medroxyprogesterone
Medroxyprogesterone 17-Acetate
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral, Synthetic
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Back to top of Main Content
